Fundraising Fox
/People
Sign in

Kate Yen

Founder

Founder at Auron Therapeutics

Wellesley Hills, Massachusetts, United States

FoundedAuron Therapeutics

Find your path to Kate

153 people in our graph share verified history with Kate — schools, employers, funds. One of them is your warm intro.

Rami HannoushunlockedKate: together at Auron Therapeutics (2022–2023)
×5Kate: together at Auron Therapeutics
×6Kate: together at Agios Pharmaceuticals

About

Kate Yen is founder and CEO of Auron Therapeutics. She holds a Ph.D. from UCLA in molecular mechanisms of eukaryotic transcriptional regulation and completed postdoctoral research under Dr. Charles Sawyers on prostate cancer biology, during which she developed the Hi-Myc transgenic mouse model. Prior to founding Auron, she worked at Merck Research Laboratories and Agios Pharmaceuticals, where she focused on identifying and validating therapeutic targets in oncology using genetically engineered mouse models.

Founder at Auron Therapeutics

Intro paths

→

In turn, Kate can intro founders to Auron Therapeutics's investors below.

Auron Therapeutics's investors · 4

Apollo Health VenturesBerlin · since 2022DCVC (Data Collective)Palo Alto · $5M – $25M checksDCVC BioPalo Alto · since 2022Polaris PartnersBoston · $500K – $5M checks · since 2025

Co-founders at Auron Therapeutics

KY
Katharine YenExecutive Officer, Director

Experience

  1. Auron TherapeuticsFounder, CEOcurrent2018 — presentNewton, Massachusetts, United States
  2. Agios PharmaceuticalsDirector, Clinical Science2009 — 2018

Skills & more

Oncology2Drug Discovery2Clinical Trials2Clinical Development2Molecular BiologyPharmaceutical Industry4cancer metabolism

From Kate's professional profile.

Frequently asked questions

Who is Kate Yen?
Kate Yen is founder and CEO of Auron Therapeutics. She holds a Ph.D. from UCLA in molecular mechanisms of eukaryotic transcriptional regulation and completed postdoctoral research under Dr. Charles Sawyers on prostate cancer biology, during which she developed the Hi-Myc transgenic mouse model. Prior to founding Auron, she worked at Merck Research Laboratories and Agios Pharmaceuticals, where she focused on identifying and validating therapeutic targets in oncology using genetically engineered mouse models.
Where does Kate Yen work?
Kate Yen is Founder of Auron Therapeutics.
What companies did Kate Yen found?
Kate Yen founded Auron Therapeutics.
Where did Kate Yen go to school?
Kate Yen studied at UCLA (Doctor of Philosophy (Ph.D.), Molecular Biology).

Founder mafias

Same school

Shared employers